TNYA

Tenaya Therapeutics, Inc.

Healthcare · Biotechnology

$276.35 sample

+0.86 (+0.31%) 1D

Market cap

$218.2B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-17

Alerts

8

Price$276.35 +13.23% 3M daily closessample

276.35238.17

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: 10% owner
Sep 17SEC8-K filed: material event
Sep 09INSInsider buy: EVP, Operations
Sep 04INSInsider buy: Director
Sep 01INSInsider sell: EVP, Operations
Aug 26INSInsider sell: General Counsel
Aug 21INSInsider sell: General Counsel
Aug 17INSInsider sell: Chief Financial Officer

Sign up to see the real TNYA record →

Company facts

SEC EDGAR registration

Name: Tenaya Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -8sample, -100 to +100
Reporting currency: USD

Who is positioning in TNYA

sample

Insiders: 14 insider transactions over 90 days, net selling, $360.7M
Congress: 5 members traded over 90 days
Institutions · 13F: 12 funds hold $2.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$6.9B +18.0% y/y

Q4 2024Q3 2026

Inventory$3.9B +4.9% y/y

Q4 2024Q3 2026

Accounts receivable$3.1B +15.0% y/y

Q4 2024Q3 2026

Total debt$8.3B +14.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $184.3B -5.5% 3M
Sample peer B: $184.1B -6.9% 3M
Sample peer C: $208.0B +12.6% 3M
Sample peer D: $132.8B +0.1% 3M
Sample peer E: $110.9B +0.0% 3M